Determining the structure of a cholesterol transporter helps to understand the mechanism by which the two component proteins work together to clear sterols from the body.

TOP INSIGHT
The 3-D atomic structure of sterol transporter could pave the way for finding targeted therapies to treat or prevent diseases related to sterol imbalance.
Specifically, the ABCG5/ABCG8 complex is involved in excretion of sterols from the liver and the intestines. Disruption by mutations in either protein can lead to the disorder sitosterolemia. Patients with sitosterolemia have elevated levels of cholesterol and other sterols in their tissues and blood, which can cause heart attacks at an early age, Dr. Rosenbaum said.
Under normal conditions, animals maintain sterol balance by limiting dietary sterol uptake from the gut and promoting sterol secretion from the liver into the bile, added Dr. Rosenbaum, a Eugene McDermott Scholar in Medical Research.
Dr. Helen Hobbs, a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Eugene McDermott Center for Human Growth and Development as well as a recent recipient of the $3 million Breakthrough Prize in Life Sciences for her work on cholesterol genetics, is the study's other corresponding author. Additionally, Dr. Hobbs is Chief of Clinical Genetics, Professor of Internal Medicine and Molecular Genetics, and holds the Eugene McDermott Distinguished Chair for the Study of Human Growth and Development, the Philip O'Bryan Montgomery, Jr., M.D. Distinguished Chair in Developmental Biology, and the 1995 Dallas Heart Ball Chair in Cardiology Research.
Lead author Dr. Jyh-Yeuan "Eric" Lee, a research scientist in the McDermott Center, said humans have 48 ABC transporters that are classified into seven subfamilies, called A to G.
In addition, Dr. Rosenbaum said, the study data could provide insight into the structural elucidation of other ABC transporters, most of which remain uncharacterized.
Source-Eurekalert
MEDINDIA




Email










